“…In closed head injury paradigms, apoE −/− mice have decreased levels of antioxidant compounds (Lomnitski et al, 1999a; Lomnitski et al, 1997) and impaired functional recovery and neuronal loss (Chen et al, 1997a; Han and Chung, 2000). Notably, treatment with exogenous apoE decrease the anatomical and functional deficits in the animal models of several neurological diseases, such as ischemic stroke (Horsburgh et al, 2000; Tu et al, 2017), of Alzheimer's disease (Sarantseva et al, 2009), traumatic brain injury (Wang et al, 2007; Lynch et al, 2005; Laskowitz et al, 2010; Kaufman et al, 2010; Hoane et al, 2009; Laskowitz et al, 2017; Cao et al, 2016), or EAE (Li et al, 2006). These studies suggest that apoE plays important roles in neuroprotection after neurological diseases and injuries.…”